Generics 10

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Clobetasol butyrate manufacturers

10 products found

Filters

10 products found

clobetasol butyrate

Cutaneous ointment 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
FDA
Manufacturer #20781
The vision of the company is to develop and promote local expertise in the pharmaceutical industry. With the mission of quality medicines, health, and well-being of people and the environment. They manufacture and market high-quality branded generics in more than 40 countries across the globe.

Manufacturer usually replies in 9 days

clobetasol butyrate

Cream 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
FDA
Manufacturer #20781
The vision of the company is to develop and promote local expertise in the pharmaceutical industry. With the mission of quality medicines, health, and well-being of people and the environment. They manufacture and market high-quality branded generics in more than 40 countries across the globe.

Manufacturer usually replies in 9 days

clobetasol butyrate + gentamicin + miconazole nitrate

Cutaneous ointment 0.05 % + 0.1 % + 2 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 6 days

Want to see all 10 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation